Pourquoi, quand et comment doser les nouveaux anticoagulants oraux?

Translated title of the contribution: Why, when and how monitor new oral anticoagulants?

A. Tamigniau, J. Douxfils, J. B. Nicolas, B. Devalet, A. S. Larock, A. Spinewine, A. S. Dincq, S. Lessire, M. Gourdin, J. B. Watelet, V. Mathieux, C. Chatelain, J. M. Dogné, B. Chatelain, F. Mullier

Research output: Contribution to journal › Review article › peer-review

125 Downloads (Pure)

Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.
Author: Douxfils, J., 24 Oct 2015
Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (External person) (Jury), Verhamme, P. B. (External person) (Jury), TEN CATE, H. (External person) (Jury) & Ageno, W. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences

Student theses